West Pharmaceutical Services Inc (WST)
366.66
+1.64
(+0.45%)
USD |
NYSE |
May 06, 16:00
366.66
0.00 (0.00%)
After-Hours: 19:02
West Pharmaceutical Services Cash from Operations (Quarterly): 118.20M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 118.20M |
December 31, 2023 | 239.10M |
September 30, 2023 | 230.10M |
June 30, 2023 | 169.20M |
March 31, 2023 | 138.10M |
December 31, 2022 | 230.80M |
September 30, 2022 | 168.90M |
June 30, 2022 | 173.10M |
March 31, 2022 | 151.20M |
December 31, 2021 | 160.80M |
September 30, 2021 | 190.10M |
June 30, 2021 | 144.40M |
March 31, 2021 | 88.70M |
December 31, 2020 | 148.70M |
September 30, 2020 | 118.60M |
June 30, 2020 | 148.10M |
March 31, 2020 | 57.10M |
December 31, 2019 | 106.40M |
September 30, 2019 | 108.10M |
June 30, 2019 | 105.10M |
March 31, 2019 | 47.60M |
December 31, 2018 | 73.20M |
September 30, 2018 | 88.40M |
June 30, 2018 | 82.00M |
March 31, 2018 | 45.00M |
Date | Value |
---|---|
December 31, 2017 | 81.50M |
September 30, 2017 | 75.80M |
June 30, 2017 | 85.30M |
March 31, 2017 | 20.70M |
December 31, 2016 | 71.80M |
September 30, 2016 | 68.40M |
June 30, 2016 | 76.20M |
March 31, 2016 | 3.00M |
December 31, 2015 | 68.00M |
September 30, 2015 | 68.80M |
June 30, 2015 | 77.50M |
March 31, 2015 | -1.90M |
December 31, 2014 | 46.00M |
September 30, 2014 | 63.90M |
June 30, 2014 | 64.20M |
March 31, 2014 | 8.80M |
December 31, 2013 | 68.80M |
September 30, 2013 | 53.30M |
June 30, 2013 | 79.50M |
March 31, 2013 | 18.90M |
December 31, 2012 | 69.80M |
September 30, 2012 | 51.60M |
June 30, 2012 | 52.20M |
March 31, 2012 | 13.80M |
December 31, 2011 | 41.80M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
57.10M
Minimum
Mar 2020
239.10M
Maximum
Dec 2023
149.74M
Average
148.40M
Median
Cash from Operations (Quarterly) Benchmarks
Becton Dickinson & Co | 515.00M |
Abbott Laboratories | 3.038B |
Masimo Corp | 77.10M |
Merit Medical Systems Inc | 36.22M |
Insulet Corp | 45.20M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -90.60M |
Cash from Financing (Quarterly) | -271.00M |
Free Cash Flow | 386.10M |
Free Cash Flow Per Share (Quarterly) | 0.3715 |
Free Cash Flow to Equity (Quarterly) | 28.20M |
Free Cash Flow to Firm (Quarterly) | 27.60M |
Free Cash Flow Yield | 1.41% |